HEOR Staff Writer

NICE’s Preparations for Evaluating New Alzheimer’s Treatments

The Future of Clinical Trials: A Shift from Artificial to Augmented to Applie...

Reassessing the Impact of Demographic Representation on Clinical Development ...

The Cost-Effectiveness of Efgartigimod Alfa (Vyvgart) in the Treatment of Mya...

Compensating for Digital Health Inequality in the National Health Service of ...

The Power of Public Health: A Look at South Africa’s HIV Treatment Prog...